Evidence map›Paper›PMID 39282498›Full record

ArticleFrontiers in cellular and infection microbiology2024

The IS

Chao Jiang, Jie Yang, Gang Xiao, Ning Xiao, Jie Hu, Yi Yang, Zhiliang Sun, Yujuan Li

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in cellular and infection microbiology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Emergence ofFrontiers in microbiology · 2026
    Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Chao Jiang *College of Basic Medical Science, Xiangnan University, Chenzhou, Hunan, China.
Jie Yang *College of Veterinary Medicine, Hunan Agricultural University, Changsha, Hunan, China.
Gang XiaoCollege of Veterinary Medicine, Hunan Agricultural University, Changsha, Hunan, China.
Ning XiaoCollege of Veterinary Medicine, Hunan Agricultural University, Changsha, Hunan, China.
Jie HuCollege of Basic Medical Science, Xiangnan University, Chenzhou, Hunan, China.
Yi YangCollege of Basic Medical Science, Xiangnan University, Chenzhou, Hunan, China.
Zhiliang SunCollege of Veterinary Medicine, Hunan Agricultural University, Changsha, Hunan, China.
Yujuan LiCollege of Basic Medical Science, Xiangnan University, Chenzhou, Hunan, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Tigecycline is a last-resort drug used to treat serious infections caused by multidrug-resistant bacteria.

Indexed as

Anti-Bacterial AgentsDucksEscherichia coliEscherichia coli InfectionsFarmsTigecyclineWhole Genome SequencingAnimalsChinaDrug Resistance, BacterialDrug Resistance, Multiple, BacterialEscherichia coli ProteinsFecesGene Transfer, HorizontalGenotypeMicrobial Sensitivity TestsAnti-Bacterial AgentsEscherichia coli ProteinsTigecyclineantimicrobial drug resistanceduckEscherichia colitet(X4)tigecycline

Identifiers

PMID39282498
PMCPMC11392914

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.